Acrivon Therapeutics Inc....

AI Score

XX

Unlock

1.67
-0.07 (-4.02%)
At close: Apr 03, 2025, 3:59 PM
1.71
2.70%
After-hours: Apr 03, 2025, 05:54 PM EDT

Acrivon Therapeutics Common Stock Statistics

Share Statistics

Acrivon Therapeutics Common Stock has 31.35M shares outstanding. The number of shares has increased by 1.54% in one year.

Shares Outstanding 31.35M
Shares Change (YoY) 1.54%
Shares Change (QoQ) 0.69%
Owned by Institutions (%) n/a
Shares Floating 21.75M
Failed to Deliver (FTD) Shares 6
FTD / Avg. Volume 0.01%

Short Selling Information

The latest short interest is 1.08M, so 3.47% of the outstanding shares have been sold short.

Short Interest 1.08M
Short % of Shares Out 3.47%
Short % of Float 4.91%
Short Ratio (days to cover) 15.38

Valuation Ratios

The PE ratio is -25.25 and the forward PE ratio is -1.88. Acrivon Therapeutics Common Stock's PEG ratio is 0.28.

PE Ratio -25.25
Forward PE -1.88
PS Ratio 0
Forward PS 0.5
PB Ratio 11.51
P/FCF Ratio -29.72
PEG Ratio 0.28
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Acrivon Therapeutics Common Stock.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 10.55, with a Debt / Equity ratio of 0.02.

Current Ratio 10.55
Quick Ratio 10.55
Debt / Equity 0.02
Debt / EBITDA -0.04
Debt / FCF -0.05
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-1.07M
Employee Count 75
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -73.87% in the last 52 weeks. The beta is 0.86, so Acrivon Therapeutics Common Stock's price volatility has been higher than the market average.

Beta 0.86
52-Week Price Change -73.87%
50-Day Moving Average 5.12
200-Day Moving Average 6.8
Relative Strength Index (RSI) 20.98
Average Volume (20 Days) 106.38K

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -89.2M
Net Income -80.56M
EBITDA -89.2M
EBIT n/a
Earnings Per Share (EPS) -0.24
Full Income Statement

Balance Sheet

The company has 39.82M in cash and 3.65M in debt, giving a net cash position of 36.17M.

Cash & Cash Equivalents 39.82M
Total Debt 3.65M
Net Cash 36.17M
Retained Earnings -196.98M
Total Assets 196.59M
Working Capital 164.41M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -65.67M and capital expenditures -2.77M, giving a free cash flow of -68.44M.

Operating Cash Flow -65.67M
Capital Expenditures -2.77M
Free Cash Flow -68.44M
FCF Per Share -0.2
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ACRV does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for ACRV is $18, which is 934.5% higher than the current price. The consensus rating is "Buy".

Price Target $18
Price Target Difference 934.5%
Analyst Consensus Buy
Analyst Count 7
Stock Forecasts

Scores

Altman Z-Score -0.3
Piotroski F-Score 3